RxDoctor Payments DataLook up a doctor →

Javier Duron Tabora, MD

Endocrinology, Diabetes & Metabolism · Bowling Green, KYNPI 1356861496

Payments from drug & device makers

$11,297in general payments, 2019–2025

Across 676 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$1K
  • Novo Nordisk$1K
  • Amgen$1K
  • Mannkind Corporation$751
  • Corcept Therapeutics$747
  • Novartis$706
  • plus $6K from 36 others

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$11,297 in reported general payments places this provider in the 65th percentile of 90 endocrinology, diabetes & metabolism providers in Kentucky.

See all endocrinology, diabetes & metabolism providers in Kentucky

Medicare billing

Part B allowed, 2024
$104,118
Medicare patients
259
Services billed
3,258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Bowling Green

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →